epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Emend
    aprepitant
  • remove Rexulti
    brexpiprazole

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Emend (aprepitant) + Rexulti (brexpiprazole)

Monitor/Modify Tx


aprepitant + brexpiprazole

if aprepitant 3-day regimen, decr. brexpiprazole dose 75% if CYP2D6 poor metabolizer or if also combined w/ moderate or strong CYP2D6 inhibitor; aprepitant single dose-regimen OK: combo may incr. brexpiprazole levels, risk of adverse effects (hepatic metabolism inhibited)

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information